Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.

PubWeight™: 1.93‹?› | Rank: Top 3%

🔗 View Article (PMC 3164878)

Published in Hum Mol Genet on February 13, 2006

Authors

Huiping Zhang1, Xingguang Luo, Henry R Kranzler, Jaakko Lappalainen, Bao-Zhu Yang, Evgeny Krupitsky, Edwin Zvartau, Joel Gelernter

Author Affiliations

1: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Articles citing this

A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet (2011) 3.94

Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol (2007) 2.18

Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet (2006) 2.15

A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry (2010) 2.02

Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav (2008) 2.00

Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74

Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet (2009) 1.73

Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet (2008) 1.59

OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend (2010) 1.55

Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. Biol Psychiatry (2015) 1.44

Genetics of alcohol dependence. Hum Genet (2009) 1.44

The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry (2007) 1.41

Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction (2009) 1.31

The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behav Brain Funct (2006) 1.28

Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest (2012) 1.26

Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev (2009) 1.18

Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci (2010) 1.16

Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus. Biol Psychiatry (2010) 1.14

Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. Hum Mol Genet (2006) 1.14

OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res (2008) 1.12

Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug Alcohol Depend (2007) 1.10

Meta-analysis of 15 genome-wide linkage scans of smoking behavior. Biol Psychiatry (2010) 1.08

Pharmacogenetics of alcohol and alcohol dependence treatment. Curr Pharm Des (2010) 1.05

Substance dependence low-density whole genome association study in two distinct American populations. Hum Genet (2008) 1.03

Association of candidate genes with antisocial drug dependence in adolescents. Drug Alcohol Depend (2008) 1.01

Initial evidence of an association between OPRM1 and adolescent alcohol misuse. Alcohol Clin Exp Res (2009) 1.00

Opiate and cocaine addiction: from bench to clinic and back to the bench. Curr Opin Pharmacol (2009) 0.99

Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. Alcohol Clin Exp Res (2008) 0.98

Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. Addict Biol (2012) 0.97

Convergence of genome-wide association and candidate gene studies for alcoholism. Alcohol Clin Exp Res (2012) 0.96

The opioid peptides enkephalin and beta-endorphin in alcohol dependence. Biol Psychiatry (2008) 0.95

Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians. BMC Med Genet (2008) 0.95

Haplotype block structure of the genomic region of the mu opioid receptor gene. J Hum Genet (2010) 0.95

The genetics of alcohol and other drug dependence. Alcohol Res Health (2008) 0.93

Personality traits of agreeableness and extraversion are associated with ADH4 variation. Biol Psychiatry (2006) 0.92

Multiple OPR genes influence personality traits in substance dependent and healthy subjects in two American populations. Am J Med Genet B Neuropsychiatr Genet (2008) 0.92

NKAIN1-SERINC2 is a functional, replicable and genome-wide significant risk gene region specific for alcohol dependence in subjects of European descent. Drug Alcohol Depend (2013) 0.92

The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy. CNS Neurol Disord Drug Targets (2008) 0.91

Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J Gastroenterol (2013) 0.91

Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations. Drug Alcohol Depend (2012) 0.88

Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. Behav Genet (2015) 0.86

Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence. J Hum Genet (2012) 0.86

Genetics of drug dependence. Dialogues Clin Neurosci (2010) 0.85

Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. Pharmgenomics Pers Med (2009) 0.85

No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. Drug Alcohol Depend (2011) 0.84

A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions. J Neurosci (2014) 0.84

The interaction of reward genes with environmental factors in contribution to alcoholism in mexican americans. Alcohol Clin Exp Res (2009) 0.83

Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res (2010) 0.83

Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses. Behav Brain Funct (2012) 0.82

Pharmacogenetics of OPRM1. Pharmacol Biochem Behav (2013) 0.81

RGS17: an emerging therapeutic target for lung and prostate cancers. Future Med Chem (2013) 0.81

Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. BMC Psychiatry (2013) 0.81

μ-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption. Alcohol Alcohol (2013) 0.81

Common and specific liability to addiction: approaches to association studies of opioid addiction. Drug Alcohol Depend (2012) 0.81

ADH1A variation predisposes to personality traits and substance dependence. Am J Med Genet B Neuropsychiatr Genet (2010) 0.81

Sex differences in NMDA receptor expression in human alcoholics. Alcohol Alcohol (2009) 0.79

The 'antisocial' person: an insight in to biology, classification and current evidence on treatment. Ann Gen Psychiatry (2010) 0.79

Variation in OPRM1 and risk of suicidal behavior in drug-dependent individuals. Am J Addict (2011) 0.78

Genetic and environmental predictors of latent trajectories of alcohol use from adolescence to adulthood: a male twin study. Alcohol Clin Exp Res (2013) 0.78

Alcohol Dependence and Genes Encoding α2 and γ1 GABAA Receptor Subunits: Insights from Humans and Mice. Alcohol Res (2012) 0.78

A psycho-genetic study of hedonic responsiveness in relation to "food addiction". Nutrients (2014) 0.77

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. Neurosci Lett (2013) 0.77

Dimensionality and Genetic Correlates of Problem Behavior in Low-Income African American Adolescents. J Clin Child Adolesc Psychol (2015) 0.77

[The endogenous opioid system and drug addiction]. Ann Pharm Fr (2010) 0.76

Case-control association study of WLS variants in opioid and cocaine addicted populations. Psychiatry Res (2013) 0.76

Strategies for performing genotype-phenotype association studies in nonhuman primates. Methods (2009) 0.75

Engineering endomorphin drugs: state of the art. Expert Opin Ther Pat (2012) 0.75

Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent. Pharmgenomics Pers Med (2012) 0.75

Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1. Mol Psychiatry (2017) 0.75

Parent and peer influences on emerging adult substance use disorder: A genetically informed study. Dev Psychopathol (2016) 0.75

Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population. Psychiatr Genet (2012) 0.75

A cis-eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use. Alcohol Clin Exp Res (2017) 0.75

Therapygenetics in mindfulness-based cognitive therapy: do genes have an impact on therapy-induced change in real-life positive affective experiences? Transl Psychiatry (2014) 0.75

Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting. Exp Brain Res (2014) 0.75

Articles cited by this

Inference of population structure using multilocus genotype data. Genetics (2000) 147.76

Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23

Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics (2003) 53.11

The structure of haplotype blocks in the human genome. Science (2002) 50.88

A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet (2003) 26.59

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06

Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet (1999) 23.67

PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics (2005) 15.95

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet (2004) 14.76

Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered (2003) 14.37

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A (1988) 11.96

Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet (2001) 10.48

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature (1996) 7.15

Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry (1992) 5.48

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67

An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet (2003) 4.61

Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet (2004) 4.51

Use of unphased multilocus genotype data in indirect association studies. Genet Epidemiol (2004) 4.51

Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry (1992) 3.55

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem (2005) 3.53

Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A (1997) 3.26

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A (1992) 3.02

Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population. Alcohol Clin Exp Res (2005) 2.35

Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. Am J Med Genet B Neuropsychiatr Genet (2005) 2.24

Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet (2002) 2.15

Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genet Epidemiol (2005) 2.09

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem (2004) 2.07

Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet B Neuropsychiatr Genet (2003) 2.07

Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet (2000) 2.05

Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend (2006) 1.96

Detection of genotyping errors and pseudo-SNPs via deviations from Hardy-Weinberg equilibrium. Genet Epidemiol (2005) 1.93

CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study. Hum Mol Genet (2005) 1.85

Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat Genet (1994) 1.82

Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry (1998) 1.72

Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet (2003) 1.71

Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology (2005) 1.66

Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry (1999) 1.66

A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem (2000) 1.65

ADH4 gene variation is associated with alcohol and drug dependence: results from family controlled and population-structured association studies. Pharmacogenet Genomics (2005) 1.58

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry (2004) 1.56

Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience (2005) 1.53

ADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case-control association studies. Neuropsychopharmacology (2006) 1.45

Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport (2003) 1.42

The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci U S A (1999) 1.41

Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett (1994) 1.39

Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet (2003) 1.29

A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet (2003) 1.25

Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport (2001) 1.22

Effect of experimenter-delivered and self-administered cocaine on extracellular beta-endorphin levels in the nucleus accumbens. J Neurochem (2003) 1.22

Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum Mutat (2002) 1.11

Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet (1997) 1.10

Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. Alcohol Clin Exp Res (2004) 1.07

A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol Psychiatry (2002) 1.06

Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet (1999) 1.06

Association of functional opioid receptor genotypes with alcohol dependence in Koreans. Alcohol Clin Exp Res (2004) 1.06

Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am J Med Genet (2001) 1.05

Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J Comp Neurol (1994) 1.04

Fine-scale mapping using Hardy-Weinberg disequilibrium. Ann Hum Genet (2001) 0.99

Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1). Alcohol Clin Exp Res (1998) 0.98

Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction. Am J Med Genet B Neuropsychiatr Genet (2003) 0.97

Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals. Alcohol (2001) 0.96

Gene polymorphisms of the mu opioid receptor in methamphetamine abusers. Ann N Y Acad Sci (2004) 0.90

Effect of acute ethanol in vivo and in vitro on the beta-endorphin system in the rat. Life Sci (1987) 0.90

Hardy-Weinberg testing of a single homozygous genotype. Genetics (2005) 0.86

Identification of alternatively spliced variants from opioid receptor genes. Methods Mol Med (2003) 0.85

Schizophrenia and other psychotic disorders in DSM-III. Schizophr Bull (1978) 0.82

Further evidence for a quantitative trait locus on murine chromosome 10 controlling morphine preference in inbred mice. Psychiatr Genet (1996) 0.80

Effects of single and dual administration of cocaine and ethanol on opioid and ORL1 receptor expression in rat CNS: an autoradiographic study. Brain Res (2003) 0.78

Introducing a new recruitment approach to sample collection for genetic association studies in opioid dependence. Eur Psychiatry (2003) 0.78

Articles by these authors

Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA (2007) 6.81

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA (2005) 4.64

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet (2003) 4.63

Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A (2004) 4.42

Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry (2006) 3.97

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66

Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend (2006) 3.40

Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol (2008) 3.13

Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet (2004) 3.10

Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend (2004) 3.09

Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). Drug Alcohol Depend (2005) 3.09

The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry (2007) 2.81

HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res (2007) 2.55

Effects of the 2011 duty hour reforms on interns and their patients: a prospective longitudinal cohort study. JAMA Intern Med (2013) 2.52

Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases. Biol Psychiatry (2011) 2.45

Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biol Psychiatry (2009) 2.44

A prospective cohort study investigating factors associated with depression during medical internship. Arch Gen Psychiatry (2010) 2.41

DCDC2 is associated with reading disability and modulates neuronal development in the brain. Proc Natl Acad Sci U S A (2005) 2.35

Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population. Alcohol Clin Exp Res (2005) 2.35

Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). Drug Alcohol Depend (2007) 2.26

Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. Am J Med Genet B Neuropsychiatr Genet (2005) 2.24

Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am J Psychiatry (2014) 2.18

Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology (2010) 2.16

Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet (2006) 2.15

Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genet Epidemiol (2005) 2.09

Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet B Neuropsychiatr Genet (2003) 2.07

Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med (2014) 2.05

Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry (2009) 1.97

Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend (2006) 1.96

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry (2004) 1.96

Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci (2008) 1.96

Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet (2006) 1.94

Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med (2005) 1.89

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res (2007) 1.86

Understanding US addiction physicians' low rate of naltrexone prescription. Drug Alcohol Depend (2003) 1.86

CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study. Hum Mol Genet (2005) 1.85

Psychometric properties of the short index of problems as a measure of recent alcohol-related problems. Alcohol Clin Exp Res (2003) 1.84

Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend (2008) 1.84

A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation. Pain (2013) 1.84

Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. Am J Hum Genet (2006) 1.82

Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet (2005) 1.80

Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry (2011) 1.76

Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology (2007) 1.71

Effects of gender and family history of alcohol dependence on a behavioral task of impulsivity in healthy subjects. J Stud Alcohol (2002) 1.69

Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial. Am J Psychiatry (2012) 1.67

Rare ADH variant constellations are specific for alcohol dependence. Alcohol Alcohol (2012) 1.66

Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry (2006) 1.66

Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects. Am J Addict (2007) 1.63

GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride. Neuropsychopharmacology (2005) 1.63

Variation in GABRA2 predicts drinking behavior in project MATCH subjects. Alcohol Clin Exp Res (2007) 1.62

A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits. Biol Psychiatry (2010) 1.62

Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety. J Clin Psychiatry (2015) 1.62

Genetic and environmental predictors of early alcohol use. Biol Psychiatry (2006) 1.60

Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment. Am J Epidemiol (2009) 1.58

ADH4 gene variation is associated with alcohol and drug dependence: results from family controlled and population-structured association studies. Pharmacogenet Genomics (2005) 1.58

Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology (2010) 1.58

Interactive effects of the serotonin transporter 5-HTTLPR polymorphism and stressful life events on college student drinking and drug use. Biol Psychiatry (2006) 1.57

Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet (2007) 1.55

Variant callers for next-generation sequencing data: a comparison study. PLoS One (2013) 1.50

Genome-wide association study of alcohol dependence implicates KIAA0040 on chromosome 1q. Neuropsychopharmacology (2011) 1.50

Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene. Neuropsychopharmacology (2007) 1.48

Serotonin transporter gene polymorphism (5-HTTLPR) and anxiety reactivity in daily life: a daily process approach to gene-environment interaction. Psychosom Med (2007) 1.47

ADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case-control association studies. Neuropsychopharmacology (2006) 1.45